SYMONDS JONATHAN purchased 25K shares of RUBIUS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $575.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/23/2018ACC: 0001104659-18-046526
Director
Since Jul 2018
+25K
Net shares
Net buyer
$575.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$23.00
Trade value
$575K
% of position
New position
7/20/2018
0.00→25K
Total
Net shares
+25K
Net value
$575K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/20/2018 | P · Purchase | +25K | $23.00 | $575K | New position | 0.00 | 25K |
| Total | +25K | $575K | ||||||
Derivative Transactions0
No derivative transactions reported